• Uncertainty reigns, but opportunity persists for biotech’s 2025

  • 2025/02/07
  • 再生時間: 9 分
  • ポッドキャスト

Uncertainty reigns, but opportunity persists for biotech’s 2025

  • サマリー

  • Universal wisdom had it that a Republican sweep in the U.S. election would favor biotech. Appointments to the new administration’s healthcare leadership make that far less certain. What effect will this and other factors have on the industry in 2025, and where are the breakthroughs likely to be found? Brian Abrahams, Head of Global Healthcare Research at RBC Capital Markets, looks ahead with in this episode of Pathfinders in Biotech.

    続きを読む 一部表示

あらすじ・解説

Universal wisdom had it that a Republican sweep in the U.S. election would favor biotech. Appointments to the new administration’s healthcare leadership make that far less certain. What effect will this and other factors have on the industry in 2025, and where are the breakthroughs likely to be found? Brian Abrahams, Head of Global Healthcare Research at RBC Capital Markets, looks ahead with in this episode of Pathfinders in Biotech.

activate_buybox_copy_target_t1

Uncertainty reigns, but opportunity persists for biotech’s 2025に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。